应用自动心肌运动定量技术评估重度主动脉瓣狭窄患者的左心室功能
该研究纳入70例重度主动脉瓣狭窄患者(按射血分数分为EF≥60%、EF 50%–59%、EF<50%三组)和30名健康对照,采用自动心肌运动定量(aCMQ)技术测量纵向峰值应变(LPS)。结果显示各SAS组LPS绝对值均显著低于对照组,EF<50%组左心室心肌功能受损最严重,aCMQ可定量评估EF≥60%的SAS患者左心室收缩功能受损程度。
要点
- 重度主动脉瓣狭窄患者纵向峰值应变(LPS)绝对值显著低于健康对照。
- EF<50%的重度主动脉瓣狭窄患者左心室心肌功能受损最严重。
- aCMQ技术可定量评估EF≥60%的重度主动脉瓣狭窄患者左心室收缩功能受损程度。
核心结论
- EF<50%的重度主动脉瓣狭窄患者左心室心肌功能受损最严重;应用aCMQ技术可精确、定量地评估EF≥60%的重度主动脉瓣狭窄患者左心室收缩功能受损的严重程度。
研究设计与样本
- 研究纳入2021年11月至2022年8月在本院接受超声心动图检查并诊断为重度主动脉瓣狭窄的患者70例为SAS组,按射血分数分为EF≥60%、EF 50%–59%、EF<50%三个亚组,同期招募健康个体30名为对照组;两组均行标准经胸超声心动图评估常规超声参数,并用自动心肌运动定量(aCMQ)软件分析动态图像获得纵向峰值应变(LPS)参数后进行统计分析。
诊断标准与关键数值
- 与对照组相比,SAS组升主动脉内径、左心房内径、室间隔舒张末期厚度、左心室后壁舒张末期厚度、收缩期峰值流速及平均压力阶差均显著升高(p<0.05)。
- 与EF≥60%的SAS组相比,EF 50%–59%的SAS组室间隔舒张末期厚度、左心室后壁舒张末期厚度、收缩期峰值流速及平均压力阶差显著升高(p<0.05)。
- EF<50%的SAS组左心室舒张末期内径、E/e'及E/A显著升高(p<0.05)。
- SAS组纵向峰值应变(LPS)绝对值显著低于对照组(p<0.05)。
- 左心室整体纵向收缩峰值应变(GLPS)各测值均与平均压力阶差呈正相关,与主动脉瓣面积指数呈中度负相关,与E/A呈中度正相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of this study is to explore the patterns of alteration in left ventricular systolic function among patients with severe aortic stenosis (SAS) through the application of automatic myocardial motion quantification (aCMQ) techniques. Furthermore, we seek to ascertain dependable quantitative markers for the assessment of impaired left ventricular function in patients with SAS and an ejection fraction (EF) ≥ 60%.
METHODS: Seventy patients who underwent echocardiography and received a diagnosis of severe aortic stenosis (SAS) in the hospital from November 2021 to August 2022 were selected for the SAS group and categorized into three subgroups based on ejection fraction (EF)-SAS group with EF ≥ 60%, SAS group with EF ranging from 50% to 59%, and SAS group with EF < 50%. Concurrently, 30 healthy individuals were recruited at the hospital during the same timeframe to serve as the control group. Participants from both groups underwent standard transthoracic echocardiography to assess conventional echocardiographic parameters. Dynamic images were examined using automatic myocardial motion quantification (aCMQ) software to derive longitudinal peak strain (LPS) parameters, which were then subjected to statistical analysis.
RESULTS: In comparison to the control group participants, the measurements of ascending aorta diameter (AoD), left atrium diameter (LAD), interventricular septal end diastolic thickness (IVSd), left ventricular posterior wall end diastolic thickness (LVPWd), peak systolic velocity (Vmax), and mean pressure gradient (MPG) were significantly higher in the SAS groups (p < 0.05). When compared to participants in the SAS group with an EF ≥ 60%, the values of IVSd, LVPWd, Vmax, and MPG in the SAS group with EF ranging from 50% to 59% were significantly elevated (p < 0.05). Similarly, left ventricular end-diastolic diameter (LVEDD), the ratio of early diastolic mitral inflow velocity to early diastolic mitral annular velocity (E/e'), and the ratio of early to late diastolic mitral inflow velocities (E/A) in the SAS group with EF < 50% were significantly elevated (p < 0.05). The absolute values of longitudinal peak strain (LPS) in the SAS groups were significantly lower in comparison to those in the control group (p < 0.05). Furthermore, all measurements of left ventricular global longitudinal systolic peak strain (GLPS) showed a positive correlation with MPG, a moderate negative correlation with aortic valve area index (AVAI), and a moderate positive correlation with E/A.
CONCLUSIONS: Patients with SAS and an EF < 50% exhibited the most profound impairment in left ventricular myocardial function. Utilizing the aCMQ technique enables the precise and quantitative evaluation of the severity of impaired left ventricular systolic function in patients within the SAS group with an EF ≥ 60%.
引用
- He J, Yang ZX, Zhang WL, et al. Evaluation of Left Ventricular Function in Patients With Severe Aortic Stenosis Utilizing Automated Cardiac Motion Quantitation Techniques. Ultrasound Med Biol. 2024. PMID: 38521696. doi:10.1016/j.ultrasmedbio.2024.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。